Mark A Magnuson, M.D. - Profile


Scientific Director, Genome Sciences Resource
Louise B. McGavock Professor, Magnuson Lab
Director, Vanderbilt Center for Stem Cell Biology
View member profile

9465 MRB-IV
2213 Garland Avenue
Vanderbilt University Medical Center
Nashville, TN, United States, 37232-0494
Phone: 615-322-7006
Fax: 615-322-6645


Research Profile

Dr. Mark A. Magnuson is the Louise B. McGavock Professor of Molecular Physiology and Biophysics, Medicine, and Cell and Developmental Biology at Vanderbilt University. 

Dr. Magnuson graduated from Luther College in 1975 and obtained his medical degree from the University of Iowa in 1979.  He completed an internship and residency in Internal Medicine at Strong Memorial Hospital in Rochester, N.Y., followed by three years at the NIH as a Research Associate.  He came to VUMC in 1985 as both a clinical fellow in Endocrinology and a senior fellow in Molecular Physiology and Biophysics before joining the faculty in 1987. 

Dr. Magnuson has authored or co-authored over 170 peer-reviewed articles.  He has been a member of numerous scientific review panels and has served on the editorial boards for Diabetes, Molecular Endocrinology, the Journal of Biological Chemistry and the American Journal of Physiology: Endocrinology and Metabolism.  He currently chairs the Executive Committee of the Beta Cell Biology Consortium and is Associate Editor for Experimental Biology and Medicine.  In 2006 he received the Sidney P. Colowick Faculty Award at Vanderbilt.  His research has been continuously funded by the National Institutes of Health for nearly 25 years.  

Dr. Magnuson is Director of the Vanderbilt Center for Stem Cell Biology, Sr. Scientific Co-Director of the Transgenic Mouse/ES Cell Shared Resource, and Scientific Advisor for the Genome Sciences Resource.  Between 1998 and 2005 he served as Director of the Office of Biomedical Sciences and Assistant Vice Chancellor for Research.

Research Keywords

stem and progenitor cell biology, cell reprogramming, endoderm and pancreas specification, next generation sequencing, bioinformatics, developmental biology, transcription factors

Publications

The following timeline graph is generated from all 171 publications. Featured publications are shown further down the page.


Citation Type Accession #
1 to 7 of 7 Publications
Guertin DA, Stevens DM, Saitoh M, Kinkel S, Crosby K, Sheen JH, Mullholland DJ, Magnuson MA, Wu H, Sabatini DM. mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. (2009) Cancer Cell 15: 148-59
Show Abstract · Added May 27, 2010
Publication19185849 (PMID)
PMC2701381 (PMCID)
10.1016/j.ccr.2008.12.017 (DOI)
Burlison JS, Long Q, Fujitani Y, Wright CV, Magnuson MA. Pdx-1 and Ptf1a concurrently determine fate specification of pancreatic multipotent progenitor cells. (2008) Dev Biol 316: 74-86
Show Abstract · Added April 15, 2010
Publication18294628 (PMID)
PMC2425677 (PMCID)
10.1016/j.ydbio.2008.01.011 (DOI)
Shiota C, Woo JT, Lindner J, Shelton KD, Magnuson MA. Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. (2006) Dev Cell 11: 583-9
Show Abstract · Added May 19, 2010
Publication16962829 (PMID)
10.1016/j.devcel.2006.08.013 (DOI)
Long Q, Shelton KD, Lindner J, Jones JR, Magnuson MA. Efficient DNA cassette exchange in mouse embryonic stem cells by staggered positive-negative selection. (2004) Genesis 39: 256-62
Show Abstract · Added May 27, 2010
Publication15286998 (PMID)
10.1002/gene.20053 (DOI)
Grimsby J, Sarabu R, Corbett WL, Haynes NE, Bizzarro FT, Coffey JW, Guertin KR, Hilliard DW, Kester RF, Mahaney PE, Marcus L, Qi L, Spence CL, Tengi J, Magnuson MA, Chu CA, Dvorozniak MT, Matschinsky FM, Grippo JF. Allosteric activators of glucokinase: potential role in diabetes therapy. (2003) Science 301: 370-3
Show Abstract · Added April 15, 2010
Publication12869762 (PMID)
10.1126/science.1084073 (DOI)
Kulkarni RN, BrĂ¼ning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. (1999) Cell 96: 329-39
Show Abstract · Added May 27, 2010
Publication10025399 (PMID)
Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, Hogan BL, Wright CV. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. (1996) Development 122: 983-95
Show Abstract · Added May 27, 2010
Publication8631275 (PMID)
See Publications Page for more
Email:mark.magnuson@vanderbilt.edu
Phone:615-322-7006
Fax:615-322-6645
Office Address
(Default) address 9465 MRB-IV
2213 Garland Avenue
Vanderbilt University Medical Center
Nashville, TN United States 37232-0494